RELATED STUDY
Therapeutic Potential Of Non-Psychotropic Cannabidiol In Ischemic Stroke
Key Findings: CBD exerts positive pharmacological effects in ischemic stroke and other chronic diseases, including Parkinson’s disease, Alzheimer’s disease, and rheumatoid arthritis. The cerebroprotective action of CBD is CB1 receptor-independent, long-lasting, and has potent anti-oxidant activity.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Japan
Year of Pub: 2010
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Not Applicable
Chemotype: Chemotype III
Receptors Studied: CB1, CB2
Citation: Hayakawa K, et al. Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke. Pharmaceuticals (Basel). 2010; 3:2197-2212. doi: 10.3390/ph3072197
Authors: Hayakawa K, Mishima K, Fujiwara M
